Zydus Cadila gets USFDA nod to market generic cancer drug
Posted by
www.biotecnika.org
The company has received final approval from the US Food and Drug
Administration (USFDA) to market its product which is a generic
version of Gleevec tablets, Zydus Cadila said in a statement.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-gets-usfda-nod-to-market-generic-cancer-drug/articleshow/75061780.cms
Subscribe to:
Post Comments (Atom)
Post a Comment